Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > How many times do we need to emphasis side effects .

<< Previous

Bullboard Posts

Next >>

Comment by gebremeskelon Aug 22, 2023 11:40am

217 Views

Post# 35599912

RE:How many times do we need to emphasis side effects .

We do not need to emphasize side effects (in the case of Keytruda) or lack of them (in the case of Ruvidar). Nor do we need to emphasize Ruvidar's superior efficacy, durability of response and small number of treatments.

We just do it for kicks while we while away the weary days and months before FDA approval.